Clinical Trials Logo

Solid Tumors or Cancers clinical trials

View clinical trials related to Solid Tumors or Cancers.

Filter by:
  • None
  • Page 1

NCT ID: NCT04844489 Completed - Multiple Sclerosis Clinical Trials

Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People

COVIVAC-ID
Start date: April 16, 2021
Phase: N/A
Study type: Interventional

Prospective, multicenter, non-comparative cohort study of immunocompromised people vaccinated against Covid-19 with the aim to know the humoral and cellular response to BNT162b2 vaccination against SARS-CoV-2 variants. This study will enroll patients in 5 parallel sub-cohorts of the same size, distinct according to the source of the immunosuppression: autoimmune or auto-inflammatory disease, HIV infection, multiple sclerosis, solid cancer, organ transplantation with prospective data collection and constitution of biological collections.